| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |